All our businesses are well positioned for growth : CS Muralidharan, Sun Pharma
At this point of time, Taro has not given any specific guidance as such and continues to be a public company. So we will be unable to offer any comment on the future performance of Taro either on the current asset basis or even if the transaction goes through. It is too early to comment.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
